RiskAnalytica The Science of Applied Risk Management Contact Us: 416-782-7475 or connect@riskanalytica.com

New reports highlight health and economic benefits of new medicines

Three new reports released today by Canada's Research-Based Pharmaceutical Companies (Rx&D) provide a combined snapshot of the enormous impact the discovery and development of innovative new medicines play in the lives of people across the country. The reports—prepared independently by KPMG, RiskAnalytica and SECOR—were commissioned by Rx&D to get a firmer understanding of the health and economic benefits generated by research-based pharmaceutical companies in Canada. They contain the first new data set detailing the economic and social impact of Canada's innovative pharmaceutical industry in five years.